Skip to main content
Livermore
Livermore
ZHEN

First Light Asset Management, LLC

SEC CIK
0001600004
Latest filing
Aug 14, 2026

Holdings in Q1 2026

Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.

Institution overview
Positions
35
+2 vs. Q4 2025
Portfolio value
$1.12B
−$192.1M (−14.7%) vs. Q4 2025
Filed
May 15, 2026
SEC
Holdings of First Light Asset Management, LLC in Q1 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
AXGNAxogen, Inc.COM4,002,768$132.6M11.9%−1,230,558−23.5%ReducedHistory
PVLAPalvella Therapeutics, Inc.COM980,758$122.3M11.0%+271,617+38.3%AddedHistory
NEONeogenomics IncCOM NEW9,729,978$72.2M6.5%−305,085−3.0%ReducedHistory
SIBNSI-BONE, Inc.COM5,353,190$67.6M6.1%+320,286+6.4%AddedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS1,560,991$62.0M5.6%−717,949−31.5%ReducedHistory
APGEApogee Therapeutics, Inc.COM576,684$48.5M4.3%+291,693+102.4%AddedHistory
AMLXAmylyx Pharmaceuticals, Inc.COM3,190,645$44.3M4.0%−164,894−4.9%ReducedHistory
TWSTTwist Bioscience CorpCOM878,848$41.8M3.7%−261,923−23.0%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM1,089,670$39.6M3.5%−104,593−8.8%ReducedHistory
MASS908 Devices Inc.COM6,072,563$37.2M3.3%+1,236,377+25.6%AddedHistory
NPCENeuroPace IncCOM2,459,966$32.3M2.9%+1,110,484+82.3%AddedHistory
EWTXEdgewise Therapeutics, Inc.COM1,001,846$31.6M2.8%−571,855−36.3%ReducedHistory
ANABAnaptysbio, IncCOM565,431$31.4M2.8%−80,807−12.5%ReducedHistory
SLPSimulations Plus, Inc.COM2,632,823$31.1M2.8%+663,906+33.7%AddedHistory
GHGuardant Health, Inc.COM280,299$25.9M2.3%−14,452−4.9%ReducedHistory
TNDMTandem Diabetes Care IncCOM NEW1,314,715$25.2M2.3%+225,222+20.7%AddedHistory
ATRCAtriCure, Inc.COM729,521$20.8M1.9%−445,924−37.9%ReducedHistory
TLSITriSalus Life Sciences, Inc.COM5,066,827$20.3M1.8%+5,066,827NewHistory
TECXTectonic Therapeutic, Inc.COM647,743$20.0M1.8%+647,743NewHistory
IRTCiRhythm Holdings, Inc.COM168,116$19.8M1.8%+14,245+9.3%AddedHistory
SEPNSepterna, Inc.COM732,860$17.6M1.6%+112,049+18.0%AddedHistory
ESTAEstablishment Labs Holdings Inc.COM307,738$17.5M1.6%−65,344−17.5%ReducedHistory
HCATHealth Catalyst, Inc.COM12,878,700$16.4M1.5%−32,241−0.2%ReducedHistory
OMCLOmnicell, Inc.COM489,846$16.4M1.5%+489,846NewHistory
KRMDKORU Medical Systems, Inc.COM3,768,380$16.3M1.5%−442,132−10.5%ReducedHistory
WGSGeneDx Holdings Corp.COM CL A242,927$15.6M1.4%+242,927NewHistory
WVEWave Life Sciences, Inc.SHS1,843,968$13.4M1.2%−9,883−0.5%ReducedHistory
VERAVera Therapeutics, Inc.CL A313,906$12.6M1.1%−555,770−63.9%ReducedHistory
MDXGMimedx Group, Inc.COM2,842,892$11.2M1.0%−196,449−6.5%ReducedHistory
BFLYButterfly Network, Inc.COM CL A2,660,167$10.7M1.0%−151,964−5.4%ReducedHistory
SGPSpyGlass Pharma, Inc.COM SHS375,000$9.72M0.9%+375,000NewHistory
ORGOOrganogenesis Holdings Inc.COM3,498,533$8.29M0.7%−364,287−9.4%ReducedHistory
PCVXVaxcyte, Inc.COM141,784$8.24M0.7%+141,784NewHistory
ELVNEnliven Therapeutics, Inc.COM201,867$7.91M0.7%+201,867NewHistory
RYTMRhythm Pharmaceuticals, Inc.COM87,181$7.58M0.7%−208,663−70.5%ReducedHistory

Sold out since Q4 2025 (5)

Positions held at the end of Q4 2025 that are gone from this filing.

Positions of First Light Asset Management, LLC sold out since Q4 2025
SecurityClassShares in Q4 2025Value in Q4 2025% of portfolio in Q4 2025History
IRONDisc Medicine, Inc.COM523,167$41.5M3.2%History
MDGLMadrigal Pharmaceuticals, Inc.COM66,831$38.9M3.0%History
ABVXAbivax S.A.SPONSORED ADS88,674$12.0M0.9%History
DYNDyne Therapeutics, Inc.COM155,231$3.04M0.2%History
iShares Russell 2000 Growth ETF464287648ETF760$245.5K<0.1%–